Published in JIMD Rep on August 22, 2012
Survival after treatment with phenylacetate and benzoate for urea-cycle disorders. N Engl J Med (2007) 3.36
Are there better guidelines for allocation in liver transplantation? A novel score targeting justice and utility in the model for end-stage liver disease era. Ann Surg (2011) 2.51
Liver allocation and distribution: possible next steps. Liver Transpl (2011) 2.14
Improved metabolic correction in patients with lysosomal storage disease treated with hematopoietic stem cell transplant compared with enzyme replacement therapy. J Pediatr (2009) 1.52
Unmasked adult-onset urea cycle disorders in the critical care setting. Crit Care Clin (2005) 1.42
Current role of liver transplantation for the treatment of urea cycle disorders: a review of the worldwide English literature and 13 cases at Kyoto University. Liver Transpl (2005) 1.32
Liver transplantation for classical maple syrup urine disease: long-term follow-up in 37 patients and comparative United Network for Organ Sharing experience. J Pediatr (2011) 1.27
Current international perspectives on hematopoietic stem cell transplantation for inherited metabolic disorders. Pediatr Clin North Am (2010) 1.21
Developmental outcomes with early orthotopic liver transplantation for infants with neonatal-onset urea cycle defects and a female patient with late-onset ornithine transcarbamylase deficiency. Pediatrics (2004) 1.04
Adult presentations of medium-chain acyl-CoA dehydrogenase deficiency (MCADD). J Inherit Metab Dis (2009) 0.96
The MELD score in patients awaiting liver transplant: strengths and weaknesses. J Hepatol (2010) 0.94
Department-related tasks and organ-targeted therapy in Fabry disease: an interdisciplinary challenge. Am J Med (2010) 0.90
Combined liver-kidney transplant for the management of methylmalonic aciduria: a case report and review of the literature. Mol Genet Metab (2007) 0.89
Decision making in liver transplant selection committees: a multicenter study. Ann Intern Med (2011) 0.85
Obstacles to residents' conducting research and predictors of publication. Acad Med (2001) 2.25
Review article: possible beneficial effects of coffee on liver disease and function. Aliment Pharmacol Ther (2007) 1.61
Exploring differences in response to treatment with peginterferon alpha 2a (40kD) and ribavirin in chronic hepatitis C between genotypes 2 and 3. J Viral Hepat (2008) 1.45
Analysis of causes of death in liver transplant recipients who survived more than 3 years. Liver Transpl (2001) 1.40
Primary biliary cirrhosis and inflammatory bowel disease. Am J Gastroenterol (1993) 1.39
Peginterferon alfa-2a (40KD) plus ribavirin in chronic hepatitis C patients who failed previous interferon therapy. Gut (2006) 1.22
Interferon-based combination anti-viral therapy for hepatitis C virus after liver transplantation: a review and quantitative analysis. Am J Transplant (2006) 1.20
Treating chronic hepatitis C with pegylated interferon alfa-2a (40 KD) and ribavirin in clinical practice. Aliment Pharmacol Ther (2006) 1.07
An independent and prospective comparison of two commercial fibrosis marker panels (HCV FibroSURE and FIBROSpect II) during albinterferon alfa-2b combination therapy for chronic hepatitis C. J Viral Hepat (2008) 1.02
Obscure gastrointestinal bleeding from an ampullary tumour in a patient with a remote history of renal cell carcinoma: a diagnostic conundrum. Can J Gastroenterol (1998) 1.01
Massive bleeding from multiple gastric ulcerations in a patient with lymphocytic gastritis and celiac sprue. J Clin Gastroenterol (1997) 0.98
Chinese herbal medicine, fulminant hepatitis, and liver transplantation. Am J Gastroenterol (1996) 0.95
Genotypic succession of mutations of the hepatitis B virus polymerase associated with lamivudine resistance. J Hepatol (2000) 0.94
Diminutive but dangerous: a case of a polypoid rectal arteriovenous malformation. Endoscopy (2002) 0.94
Pneumocystis pneumonia in solid organ transplant recipients: not yet an infection of the past. Transpl Infect Dis (2012) 0.90
Coexisting carcinoid tumors in familial adenomatous polyposis-associated upper intestinal adenomas. Am J Gastroenterol (1999) 0.88
Liver test abnormalities in multiple sclerosis: findings from placebo-treated patients. Neurology (2006) 0.87
Monocytic cells synthesize, adhere to, and migrate on laminin-8 (alpha 4 beta 1 gamma 1). J Immunol (2000) 0.86
Alteration of the dismal natural history of fibrosing cholestatic hepatitis secondary to hepatitis B virus with the use of lamivudine. Transplantation (1997) 0.85
Adherence to assigned dosing regimen and sustained virological response among chronic hepatitis C genotype 1 patients treated with boceprevir plus peginterferon alfa-2b/ribavirin. Aliment Pharmacol Ther (2013) 0.84
Hepatitis C infection and B-cell non-Hodgkin's lymphoma in British Columbia: a cross-sectional analysis. Ann Oncol (1999) 0.84
Clinical trial: exposure to ribavirin predicts EVR and SVR in patients with HCV genotype 1 infection treated with peginterferon alpha-2a plus ribavirin. Aliment Pharmacol Ther (2008) 0.83
Liver biochemistry abnormalities in a quaternary care lipid clinic database. Ann Hepatol (2008) 0.82
Primary protein-losing enteropathy in anti-double-stranded DNA disease: the initial and sole clinical manifestation of occult systemic lupus erythematosus? J Clin Gastroenterol (2001) 0.82
Colonic malakoplakia in a liver transplant recipient. Can J Gastroenterol (2007) 0.81
Failure of ketoprofen and interferon combination therapy to improve interferon-resistant chronic hepatitis C. Can J Gastroenterol (1997) 0.80
Impaired exercise performance after successful liver transplantation. Transplantation (2001) 0.80
Correlation between physiological assessment and outcome after liver transplantation. Am J Surg (2000) 0.79
Assessment of immunologic status of liver transplant recipients by peripheral blood mononuclear cells in response to stimulation by donor alloantigen. Ann Surg (1999) 0.78
Hyperammonemia after heart-lung transplantation. Gastroenterology (1997) 0.76
Survival after liver transplantation for hepatitis C is unchanged over two decades in Canada. Can J Gastroenterol (2008) 0.76
Donor-specific stimulation of peripheral blood mononuclear cells from recipients of orthotopic liver transplants is associated, in the absence of rejection, with type-2 cytokine production. Immunol Lett (1998) 0.76
A study of the pharmacokinetic profile of low-dose hepatitis B immune globulin in long-term liver transplant recipients for chronic hepatitis B infection. Am J Transplant (2001) 0.75
Hepatitis C and B-cell non-Hodgkin's lymphoma: a geographically variable association? Am J Med (2000) 0.75
Crohn's disease, HIV, and AIDS. Am J Gastroenterol (1995) 0.75
All that bleeds is not infliximab-refractory ulcerative colitis. Can J Gastroenterol (2009) 0.75
Orthotopic liver transplantation in a patient with carbamyl phosphate synthetase deficiency and cystic fibrosis. Paediatr Child Health (2003) 0.75
Lung dysfunction and chronic liver disease. Ann Intern Med (1996) 0.75
Lovastatin and cholestasis. CMAJ (1993) 0.75
Tomorrow's challenge in liver transplantation: diminishing the imbalance between donor organ availability and need. Gut (1998) 0.75
The use of interferon-alpha 2B in the treatment of chronic viral hepatitis in patients with preexisting idiopathic thrombocytopenic purpura. Am J Gastroenterol (1995) 0.75
Palliative high-dose octreotide in a case of severe AIDS-related diarrhea. Ann Pharmacother (1994) 0.75
Recurrent hepatocellular carcinoma after liver transplantation mimicking post-transplantation lymphoproliferative disorder. Australas Radiol (2005) 0.75
Hepatic abscesses after liver transplantation secondary to traumatic intrahepatic bile duct injuries in a cadaveric allograft donor. Transpl Int (2004) 0.75
De Novo Crohn's disease in AIDS: Crohn's disease or Crohn's "syndrome"? J Clin Gastroenterol (1998) 0.75
Issues in organ procurement: presumed consent, bioethical type II errors, and organ registries. Ann R Coll Physicians Surg Can (1998) 0.75
Carcinoid tumors of the small intestine are uncommon, indolent, slow growing, slow metastasizing, neuroendocrine lesions. World J Surg (1994) 0.75
Primary induction with mycophenolate mofetil and corticosteroids in a liver transplant recipient with hepatorenal syndrome. Ann Pharmacother (1998) 0.75
Assessing virologic efficacy of combination lamivudine and low-dose hepatitis B immune globulin posttransplantation with the ultrasensitive digene hybrid capture II assay. Liver Transpl (2000) 0.75
Peritoneal dialysis after orthotopic liver transplant surgery. Perit Dial Int (2006) 0.75
Acute pseudohepatitis in a chronic substance abuser secondary to occult seat belt injury. Can J Gastroenterol (1999) 0.75
A case of recurrent pyogenic cholangitis. Dig Liver Dis (2007) 0.75
Post-surgical shunt hepatopulmonary syndrome in a case of non-cirrhotic portal hypertension: lack of efficacy of shunt reversal. Eur J Gastroenterol Hepatol (1999) 0.75
Liver enzymes as surrogate markers of hepatitis C histopathology--avoiding the liver biopsy needle? Can J Gastroenterol (2001) 0.75
Diabetes mellitus after liver transplantation: another extrahepatic manifestation of hepatitis C. Can J Gastroenterol (2001) 0.75